Enhancing the upstream regulatory mechanism of CD36, including peroxisome proliferator-activated receptor γ (PPAR γ) and the nuclear factor erythroid 2–related factor 2 (Nrf2), is a potential approach to promoting CD36-mediated hematoma clearance. This evidence concerns the gene CD36 and hematoma.